TranslatiOnal Registry for CardiomyopatHies-Plus (TORCH-Plus-DZHK21)

The overarching aim of TORCH-Plus is to create a large-scale prospective data & biomaterial repository of patients with non-ischemic cardiomyopathies (CMP). The scientists want to study clinical outcomes, familial structures, phenotype-genotype associations, autoimmunity, and inflammatory mechanisms as well as gender-related aspects. By long-term follow-up and systematic evaluation of CMP-related mechanisms, TORCH-Plus aims to identify and validate novel risk stratification algorithms to improve the outcome of patients ultimately.

Publications

Translational Registry for Cardiomyopathies (Torch) – Rationale and First Results. Seyler, C. et al. ESC heart failure, (2017).

All publications of this trial can be found here

Principal Investigators

Principal investigator: Benjamin Meder (Heidelberg)

Study recruitment is available in these cities

The map only displays recruitment locations within Germany.